论文部分内容阅读
Accumulating evidences have showed that pharmacokinetics of some drugs was altered by diabetes mellitus, leading to changes of pharmacodynamic/toxic effects.Pro-dosage prediction ofpharmacokinetics was needed for appropriate optimization of dose for diabetic patients.Aim of study was to develop a novel physiologically based pharmacokinetic (PBPK) model for predicting pharmacokinetics of drugs in type 2 diabetic patients quantitatively.